Role of gene-gene/gene-environment interaction in the etiology of eastern Indian ADHD probands

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 577-587

  Das, Manali ^a   Bhowmik, Aneek Das ^a   Bhaduri, Nipa ^a,c   Sarkar, Kanyakumarika ^a   Ghosh, Paramita ^a   Sinha, Swagata ^a   Ray, Anirban ^b   Chatterjee, Anindita ^a   Mukhopadhyay, Kanchan ^a  

^a Manovikas Biomedical Research and Diagnostic Centre   (India)

^b BANKURA SAMMILANI MEDICAL COLLEGE   (India)

^c Bengal Intelligent Park Building Tower B   (India)

Author keywords

Dopaminergic genes; Gene environment interaction; Gene gene interaction; Haplotype analysis; Neurobehavioral disorder

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; GENOMIC DNA;

3' UNTRANSLATED REGION; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD SAMPLING; CASE CONTROL STUDY; CAUCASIAN; CHILD; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ETHNIC GROUP; EXON; FAMILY STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INDIAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; EPISTASIS, GENETIC; EXONS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC TESTING; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; INTRONS; MALE; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79952898576     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.12.027     Document Type: Article

References (99)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Washington, DC. 4th ed.
2. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995, 65:1157-1165.
3. Asherson P., Brookes K., Franke B., Chen W., Gill M., Ebstein R.P., et al. Confirmation that a specific haplotypes of the dopamine transporter gene is associated with combined-type ADHD. Am J Psychiatry 2007, 164:674-677.
4. Bakermans-Kranenburg M.J., Van Ijzendoorn M.H. No association of the dopamine D4 receptor (DRD4) and -521 C/T promoter polymorphisms and infant attachment disorganization. Attach Hum Dev 2004, 6:211-218.
5. Bakker S.C., van der Meulen E.M., Oteman N., Schelleman H., Pearson P.L., Buitelaar J.K., et al. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am J Med Genet Neuropsychiatr Genet 2005, 132:50-52.
6. Banerjee T.D., Middleton F., Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Found Acta Paediatr 2007, 96:1269-1274.
7. Barr C.L., Feng Y., Wigg K.G., Schachar R., Tannock R., Roberts W., et al. 5'-untranslated region of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 2001, 105:84-90.
8. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
9. Bennett F.C., Brown R.T., Craver J., Anderson D. Stimulant medication for child with attention-deficit/hyperactivity disorder. The pediatric clinics of North America: attention-deficit/hyperactivity disorder 1999, 929-944. W.B Saunders, Philadelphia. A.M. Morgan (Ed.).
10. Bhaduri N., Mukhopadhyay K. Correlation of plasma dopamine β-hydroxylase activity with polymorphisms in DBH gene: a study on Eastern Indian population. Cell Mol Neurobiol 2008, 28:343-350.
11. Bhaduri N., Das M., Sinha S., Chattopadhyay A., Gangopadhyay P.K., Chaudhuri K., et al. Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. Am J Med Genet Neuropsychiatr Genet 2006, 141:61-66.
12. Bhaduri N., Sarkar K., Sinha S., Chattopadhyay A., Mukhopadhyay K. Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from eastern India. Cell Mol Neurobiol 2010, 30:265-274.
13. Bharat Raj J. AIISH norms on SFB with Indian children. J AIISH 1971, 2:34-39.
14. Brookes K.J., Mill J., Guindalini C., Curran S., Xu X., Knight J., et al. A common haplotypes of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatry 2006, 63:74-81.
15. Carrasco X., Rothhammer P., Moraga M., Henríquez H., Chakraborty R., Aboitiz F., et al. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am J Med Genet Neuropsychiatr Genet 2006, 141:51-54.
16. Caspi A., Langley K., Milne B., Moffitt T.E., O'Donovan M., Owen M.J., et al. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2008, 65:203-210.
17. Chen C.H., Lee Y.R., Liu M.Y., Wei F.C., Koong F.J., Hwu H.G., et al. Identification of a BglI polymorphism of catechol-O-methyltransferase (COMT) gene, and association study with schizophrenia. Am J Med Genet 1996, 67:556-559.
18. Cheuk D.K., Wong V. Meta-analysis of association between a catechol-O-methyl transferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet 2006, 36:651-659.
19. Civelli O., Bunzow J.R., Grandy D.K., Zhou Q.-Y., Van Tol H.H. Molecular biology of the dopamine receptors. Eur J Pharmacol Mol Pharmacol Sect 1991, 207:277-286.
20. Conners C.K., Parker J.D.A., Sitarenios G., Epstein J.N. The Revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998, 26:257-268.
21. Cook E.H., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Keiffer J.E., et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995, 56:993-998.
22. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., et al. Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 1998, 102:533-540.
23. Das M., Mukhopadhyay K. DAT1 3'-UTR 9R allele: preferential transmission in Indian children with attention deficit hyperactivity disorder. Am J Med Genet Neuropsychiatr Genet 2007, 144:826-829.
24. Das M., Das Bhowmik A., Sinha S., Chattopadhyay A., Chaudhuri K., Singh M., et al. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children. Am J Med Genet Neuropsychiatr Genet 2006, 141:637-642.
25. David S.P., Munafo M.R., Murphy M.F.G., Proctor M., Walton R.T., Johnstone E.C. Genetic variation in the dopamine D4 receptor gene and smoking cessation: follow-up of a randomized clinical trial of transdermal nicotine patch. Pharmacogenomics J 2008, 8:122-128.
26. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Bella D., et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 1999, 8:621-624.
27. Ding Y.-C., Chi H.-C., Grady D.L., Morishima A., Kidd J.R., Kidd K.K., et al. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci 2002, 99:309-314.
28. Domschke K., Sheehan K., Lowe N., Kirley A., Mullins C., O'Sullivan R., et al. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet Neuropsychiatr Genet 2005, 134:110-114.
29. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003, 25:115-221.
30. Faraone S.V., Doyle A.E., Mick E., Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1052-1057.
31. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., et al. Molecular genetics of attentiondeficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323.
32. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001, 1:152-156.
33. Gabriela M.L., John D.G., Magdalena B.V., Ariadnaa G.-S., Franciscob De la P.-O., Liz S.-M., et al. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Neurosci Lett 2009, 451:257-260.
34. Grady D.L., Chi H.C., Ding Y.C., Smith M., Wang E., Schuck S., et al. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry 2003, 8:536-545.
35. Guan L., Wang B., Chen Y., Yang L., Li J., Qian Q., et al. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry 2009, 14:546-554.
36. Guindalini C., Howard M., Haddley K., Laranjeira R., Collier D., Ammara N., et al. A dopamine transporter gene functional variant associated with cocaine abuse in Brazilian sample. Proc Natl Acad Sci 2006, 103:4552-4557.
37. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382.
38. Hawi Z., McCarron M., Kirley A., Fitzgerlad D.G., Gill M. No association of the dopamine D4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet Neuropsychiatr Genet 2000, 96:268-272.
39. Hawi Z., Lowe N., Kirley A., Gruenhage F., Nöthen M., Greenwood T., et al. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 2003, 8:299-308.
40. Hawi Z., Segurado R., Conroy J., Sheehan K., Lowe N., Kirley A., et al. Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. Am J Hum Genet 2005, 77:958-965.
41. Hess C., Reif A., Strobel A., Boreatti-Hümmer A., Heine M., Lesch K.P., et al. A functional dopamine-b-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 2009, 116:121-130.
42. Hotamisligil G.S., Breakefield X.O. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991, 49:383-392.
43. Kereszturi E., Király O., Csapó Z., Tamok Z., Gadaros J., Sasvári-Székely M., et al. Analysis of the dopamine D4 receptor gene variants in attention deficit hyperactivity disorder. Neuropsychopharmacol Hung 2007, 9:11-18.
44. Kieling C., Genro J.P., Hutz M.H., Rohde L.A. The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet Neuropsychiatr Genet 2008, 147:485-490.
45. Kim C.-H., Zabetian C.P., Cubells J.F., Cho S., Biaggioni I., Cohen B.M., et al. Mutations in the dopamine β-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 2002, 108:140-147.
46. Kim J.W., Kim B.N., Cho S.C. The dopamine transporter gene and the impulsivity phenotype in attention deficit hyperactivity disorder: a case-control association study in a Korean sample. J Psychiatr Res 2006, 40:730-737.
47. Kopeckova M., Paclt I., Petrasek J., Pacltova D., Malikova M., Zagatova V. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuroendocrinol Lett 2008, 29:246-251.
48. Kotler M., Manor I., Sever Y., Eisenberg J., Cohen H., Ebstein R.P., et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet 2000, 96:278-281.
49. Lachman H., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
50. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science 1994, 265:2037-2048.
51. Lawson D.C., Turic D., Langley K., Pay H.M., Govan C.F., Norton N., et al. Association analysis of monoamine A and attention deficit hyperactivity disorder. Am J Med Genet Neuropsychiatr Genet 2003, 116B:84-89.
52. Lenth R.V. Statistical power calculations. J Anim Sci 2007, 85:E24-E29.
53. Leung P.W., Lee C.C., Hung S.F., Ho T.P., Tang C.P., Kwong S.L., et al. Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. Am J Med Genet Neuropsychiatr Genet 2005, 133:54-56.
54. Lewontin R.C. On measures of gametic disequilibrium. Genetics 1988, 120:849-852.
55. Li D., Sham P.C., Owen M.J., He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder. Hum Mol Genet 2006, 15:2276-2284.
56. Lichter J.B., Barr C.L., Kennedy J.L., van Tol H.H., Kidd K.K., Livak K.J., et al. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993, 2:767-773.
57. Lobo I. Internal and external environmental factors, like gender and temperature, influence gene expression. Nature Education 2008, 1(1).
58. Lowe N., Kirley A., Mullins C., Fitzgerald M., Gill M., Hawi Z. Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with SNP-616. Am J Med Genet Neuropsychiatr Genet 2004, 131:33-37.
59. Lung F.W., Yang P., Cheng T.S., Kao W.T. No allele variation of the MAOA gene promoter in male Chinese subjects with attention deficit hyperactivity disorder. Neuropsychobiology 2006, 54:147-151.
60. Maher B.S., Marazita M.L., Ferrell R.E., Vanyukov M.M. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr Genet 2002, 12:207-215.
61. Manor I., Tyano S., Eisenberg J., Bachner-Melman R., Kotler M., Ebstein R.P. The short DRD4 repeat confers risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry 2002, 7:790-794.
62. Manor I., Tyano S., Mel E., Eisenberg J., Bachner-Melman R., Kotler M., et al. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 2002, 7:626-632.
63. Manuck S.B., Flory J.D., Ferrell R.E., Mann J.J., Muldoon M.F. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 2000, 95:9-23.
64. Martin E.R., Ritchie M.D., Hahn L., Kang S., Moore J.H. A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet Epidemiol 2006, 30:111-123.
65. Mei H., Ma D., Ashley-Koch A., Martin E.R. Extension of multifactor dimensionality reduction for identifying multilocus effects in the GAW14 simulated data. BMC Genet 2005, 6:S145-S149.
66. Mei H., Cuccaro M.L., Martin E.R. Multifactor dimentionality reduction-phenomics: a novel method of capture genetic heterogeneity with use of phenotypic variables. Am J Hum Genet 2007, 81:1251-1261.
67. Mill J., Asherson P., Browes C., D'Souza U., Craig I. Expression of the dopamine transporter gene is regulated by the 3'UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet Neuropsychiatr Genet 2002, 114:975-979.
68. Mill J., Fisher N., Curran S., Richards S., Taylor E., Asherson P. Polymorphisms in the dopamine D4 receptor gene and attention deficit hyperactivity disorder. NeuroReport 2003, 14:1463-1466.
69. Mill J., Caspi A., Williams B.S., Craig I., Taylor A., Polo-Tomas M., Berridge C.W., Poulton R., Moffitt T.E. Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Arch Gen Psychiatry 2006, 63:462-469.
70. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998, 16:1215.
71. Moore J.H., White B.C. Tuning relief for genome-wide genetic analysis. Lect Notes Comput Sci 2007, 4447:166-175.
72. Moore J.H., Gilbert J.C., Tsai C.T., Chiang F., Holden T., Barney N., et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 2006, 241:252-261.
73. Mukherjee N., Kidd K.K., Pakstis A.J., Speed W.C., Li H., Tarnok Z., et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol Psychiatry 2010, 15:216-225.
74. Nagatsu T., Udenfriend S. Photometric assay of dopamine β-hydroxylase activity in human blood. Clin Chem 1972, 18:980-983.
75. Oades R.D. Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res. 2002, 130:97-102.
76. O'Connell J.R., Weeks D.E. PedCheck: a program for identifying genotype incompatibilities in linkage analysis. Am J Hum Genet 1997, 63:259-266.
77. Okuyama Y., Ishiguro H., Toru M., Arinami T. A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia. Biochem Biophys Res Commun 1999, 258:292-295.
78. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
79. Purper-Ouakil D., Wohl M., Mouren M.C., Verpillat P., Ades J., Gorwood P. Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 2005, 15:53-59.
80. Qian Q., Wang Y., Li J., Yang L., Wang B., Zhou R., et al. Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population. Am J Med Genet Neuropsychiatr Genet 2007, 144:200-206.
81. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., et al. Multifactor dimensionality reduction reveals high-order interactions among estrogen metabolism genes in sporadic breast cancer. Am J Hum Genet 2001, 69:138-147.
82. Roman T., Schmitz M., Polanczyk G., Eizirik M., Rohde L.A., Hutz M.H. Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet Neuropsychiatr Genet 2001, 105:471-478.
83. Sabol S.Z., Hu S., Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998, 103:273-279.
84. Schoots O., Van Tol H.H.M. The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics J 2003, 3:343-348.
85. Shih J.C., Thompson R.F. Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 1999, 65:593-598.
86. Smith T.F. Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. Am J Med Genet Neuropsychiatr Genet 2010, 153:1189-1199.
87. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., Griffin S. Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996, 35:409-432.
88. Terwilliger J.D., Ott J. A haplotype-based "haplotype relative risk" approach to detecting allelic association. Hum Hered 1992, 42:337-346.
89. Thapar A., O'Donovan M.C., Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 2005, 14(spec No. 2):R275-R282.
90. Thapar A., Langley K., Asherson P., Gill M. Gene-environment interplay in attention-deficit hyperactivity disorder and the importance of a developmental perspective. Br J Psychiatry 2007, 190:1-3.
91. Thomas T.C., Kruzich P.J., Joyce B.M., Gash C.R., Suchland K., Surgener S.P., et al. Dopamine D4 receptor knockout mice exhibit neurochemical changes consistent with decreased dopamine release. J Neurosci Meth 2007, 166:306-314.
92. Todd R.D., Huang H., Smalley S.L., Nelson S.F., Willcutt E.G., Pennington B.F., et al. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. J Child Psychol Psychiatry 2005, 46:1067-1073.
93. Wechsler D. Wechsler Intelligence Scale for Children-third edition: manual 1991, The Psychological Corporation, San Antonio.
94. Xu X., Brookes K., Chen C.-K., Huang Y.-S., Wu Y.-Y., Asherson P. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry 2007, 7:10.
95. Yang B., Chan R.C., Jing J., Li T., Sham P., Chen R.Y. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3'-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet Neuropsychiatr Genet 2007, 144:541-550.
96. Yang J.-W., Jang W.-S., Hong S.D., Ji Y.L., Kim D.H., Park J., et al. A case-control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit hyperactivity disorder: Evidence of association with the -521 C/T SNP. Prog Neuro-Psychopharmacol Biol Psychiatry 2008, 32:243-248.
97. Zabetian C.P., Buxbaum S.G., Elston R.C., Köhnke M.D., Anderson G.M., Gelernter J., et al. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 2003, 72:1389-1400.
98. Zhang H.B., Wang Y.F., Li J., Wang B., Yang L. Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder. Zhonghua Er Ke Za Zhi 2005, 43:26-30.
99. Zhou K., Chen W., Buitelaar J., Banaschewski T., Oades R.D., Franke B., et al. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am J Med Genet Neuropsychiatr Genet 2008, 147:1481-1487.